As per the American Academy of Ophthalmology report, smoking leads to major ocular pains and eye diseases, including Age-related macular degeneration, diabetic retinopathy, dry eyes, cataracts and optic nerve problems. Smoking increases the chances of damage in the eye’s optic nerve, which results in clouding of the lens, glaucoma, and dry eye syndromes. Hence, increase in the cases of eye diseases will expected to enhance the market growth.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

Data Bridge Market Research analyses a growth rate in the Global Ocular Pain Market in the forecast period 2022-2029. The expected CAGR of global ocular pain market is tend to be around 8% in the mentioned forecast period. Increasing healthcare expenditure and growing geriatric population and will likely to increase the growth of the global ocular pain market.

Rising prevalence of ophthalmic disorders and ocular pains is expected to drive the market's growth rate

Ophthalmic disorders are the major cause of ocular and orbital pain in an eye. Ocular pains occur over the surface of eyes, such as burning, scratching, or itching sensation due to various reasons, including infection, irritation from foreign objects, or trauma. Mostly the person’s eye lashes, piece of dirt, dust, smoke and some harsh eye cosmetics leads to ocular pain, watery eyes , redness  and among others. WebMD LLC reported that the In January 2019 prevalence from 8% has increased to 10% of every eye-related emergency care visit. These factors state that this is the major driver for the market's growth.

Segment Analysis:

The ocular pain market is segmented on the basis of disease type, type, application, route of administration, drug type, distribution channel and end-user.

• On the basis of disease type, the global ocular pain market is segmented into ocular pain with eye diseases and ocular pain without eye diseases.

• The hospitals segment of end-users segment is anticipated to distribution channel the ocular pain market

  The hospitals segment is dominating the global ocular pain market with a market share of 28.24% due to rising disposable income and healthcare expenditure in developing countries and increasing government funds provided for constructions of hospital with eye care sections.

  Major Players

  Data Bridge Market Research recognizes the following companies as the major ocular pain market players in ocular pain market Aerie Pharmaceuticals, Inc. (U.S.), Bausch Health (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Amorphex Therapeutics Holdings, Inc (U.S.), Alcon (Switzerland), Bayer AG (Germany), Carl Zeiss Meditec AG (Germany), HumanOptics Holding AG (Germany)

For more detailed information about ocular pain market report, click here – https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

Browse More Reports: 

Global Bovine Ephemeral Fever Vaccines Market

Global Non-Thermal Pasteurization in Dairy Industry Market

Global Gallbladder Cancer Treatment Market

Global Leiomyosarcoma Treatment Market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]